Tag: David Anderson

The below Parliamentary question was asked by David Anderson on 2015-11-03.

To ask the Secretary of State for Energy and Climate Change, pursuant to the Answer of 29 June 2015 to Question 3036, whether the estimated reduction in household bills in 2030 indicated in that Answer has changed to take into account the deal on nuclear new build with the Chinese government.

Andrea Leadsom

We currently estimate that a new nuclear programme could reduce average household bills by up to around £30 (real 2012 prices) in 2030. This is calculated by comparing the costs for consumers in a modelled scenario for the future electricity mix with Hinkley Point C and a further roll out of the new nuclear programme with the cost for consumers in a scenario where there are no new nuclear power stations by 2030. Savings could be higher or lower depending on changes in the cost of alternative generation technologies and what mix of technologies would ultimately be used. Earlier analysis had identified a higher saving, but other low carbon energy technologies have become far more cost competitive which has brought down the cost.

The below Parliamentary question was asked by David Anderson on 2015-11-26.

To ask the Secretary of State for Energy and Climate Change, how much has been paid into the Exchequer from surpluses accrued by the Mineworkers’ Pension Scheme since privatisation of the coal industry.

Andrea Leadsom

I refer the hon. Member to House of Commons Library Briefing Paper Number SN01189 dated 25 November 2015 which contains at page 17 a table showing the total gross payments made to the Guarantor from the Mineworkers’ Pension Scheme since privatisation:

http://researchbriefings.files.parliament.uk/documents/SN01189/SN01189.pdf

“

The below Parliamentary question was asked by David Anderson on 2016-01-05.

To ask the Secretary of State for Health, what assessment he has made of demand for clinical trial capacity at UK muscle centres; and if he will make a statement.

George Freeman

The United Kingdom is a world–leader in neuromuscular research, bringing a combination of excellent translational science, well-defined patient cohorts and a sophisticated and successful clinical research system. These attributes make the UK an outstanding location for the global life sciences industry to undertake clinical trials and collaborate with leading clinical scientists.

The National Health Service and the Department’s National Institute for Health Research (NIHR) are working collaboratively to support the increasing number of clinical trials in neuromuscular disease.

The current pipeline of neuromuscular studies for 2016 includes four phase I studies, six phase II studies, three phase III studies and one phase IV study.

Currently, the most intensive trials are supported in Great Ormond Street Hospital, London and in the John Walton Neuromuscular Centre in Newcastle, where NIHR supports dedicated clinical research facilities alongside the Medical Research Council funded muscle research centres. These centres supported colleagues at Alder Hey Hospital, Liverpool, to collaborate in a recent study supported by the NIHR Alder Hey Clinical Research Facility.

Building on these successes, the NIHR is using its Clinical Research Network and Biomedical Research Centres to increase capacity and expertise at existing sites and prepare other muscle centres to be able to support the pipeline of studies. Additionally, NIHR leaders have engaged with patient organisations for neuromuscular disease and presented innovative models to enable charities to partner the NHS in developing more capacity in existing and new sites.

The below Parliamentary question was asked by David Anderson on 2016-01-20.

To ask the Secretary of State for Defence, if he will make it his policy that the House be given an opportunity to debate in advance any decision to deploy UK Reaper aircraft outside Syria and Iraq.

Michael Fallon

No.

The below Parliamentary question was asked by David Anderson on 2016-01-28.

To ask the Secretary of State for Defence, if the Prime Minister will take steps to speed up the legal process for cases involving ex-service personnel who have contracted mesothelioma; and if he will consider awarding equal compensation to the relatives of service personnel who have died while the process is ongoing.

Mark Lancaster

The Government has continuously made compensation available under the War Pensions Scheme for injuries, illness or disease caused by service before 6 April 2005, including mesothelioma. On 11 January 2016 (Official Report, column 612-613) I informed the House that 11 April 2016 would be the earliest date from which we could provide the option of a lump sum payment to Service veterans diagnosed with mesothelioma on or after 16 December 2015. If an accepted claim is concluded before 11 April 2016 and the individual has opted for a lump sum, payment of a War Disablement Pension and any supplementary allowances will begin in the normal way until the lump sum can be paid. The lump sum will be reduced to reflect the amounts paid until that point. If a claimant who has signed an option form to receive the lump sum dies before 11 April 2016 the lump sum will be paid to the veteran’s designated recipient.

The below Parliamentary question was asked by David Anderson on 2016-02-10.

To ask the Secretary of State for Health, if he will take steps to ensure that all clinical commissioning groups take account of the findings of the Commission on Acute Psychiatric Care’s review led by Lord Crisp before they take steps to alter in-patient provision.

Alistair Burt

Clinical commissioning groups have responsibility for ensuring that they are meeting the needs of those requiring acute psychiatric care. They are supported, and held to account for improving patient outcomes, by NHS England.

Both the Department and NHS England are considering the Commission’s recommendations. In the meantime, we have been clear that local areas should be making immediate improvements and phasing out ‘out of area’ treatments.

The below Parliamentary question was asked by David Anderson on 2016-02-26.

To ask the Secretary of State for Communities and Local Government, what his Department’s timetable is for the legislative process for election of a Regional Mayor in the north east of England.

James Wharton

Our intention is that secondary legislation to enable the election of a mayor for the North East Combined Authority in May 2017 will be made by November 2016.

The below Parliamentary question was asked by David Anderson on 2016-03-08.

To ask the Secretary of State for Health, what estimate he has made of the effect on cost and on bed capacity of delayed hospital discharge at the Lane Fox Respiratory Unit at St Thomas’ Hospital, London; and if he will make a statement.

Alistair Burt

The information is not collected centrally and no estimate has been made.

The below Parliamentary question was asked by David Anderson on 2016-04-08.

To ask the Secretary of State for Transport, what assessment his Department has made of the potential health risks of the use of lasers by driverless vehicles.

Andrew Jones

The General Product Safety Regulations prohibit a product from being placed on the market, or otherwise supplied, unless it is safe. The lead department for these regulations is the Department for Business, Innovation and Skills.

The below Parliamentary question was asked by David Anderson on 2016-04-21.

To ask the Minister for the Cabinet Office, if the Government will consult on setting up a Commissioner for Older People.

Mr Oliver Letwin

There is no current plan for Government to consult on setting up a Commissioner for Older Persons.